1. Anti-inflammatory Therapy for Acute Lung Injury
Craig Metz, Ph.D. 
CHEST 
Volume 100, Issue 4, Pages (October 1991)
DOI: /chest
Copyright © 1991 The American College of Chest Physicians Terms and Conditions

2. FIGURE 1
Major features in progression of animal and clinical pulmonary injury. TxB2, Thromboxane B2; PGI2, prostaglandin I2; HR, heart rate; FIo2, inspired oxygen tension; a/ao2 gradient, alveolar-arterial oxygen tension gradient; PMN, polymorphonuclear neutrophil Pa, mean arterial perfusing pressures; PEEP, positive end-expiratory pressure; LP/TP, lymph-to-plasma total protein ratios; CO, cardiac output; PMP, pulmonary microvascular permeability; and MPSS, methyprednisolone sodium succinate.
CHEST  , DOI: ( /chest )
Copyright © 1991 The American College of Chest Physicians Terms and Conditions

3. FIGURE 2
Diagrammatic representation of arachidonic acid cascade, demonstrating where various anti-inflammatory agents discussed would modify production of vasoconstrictor and vasodilator prostaglandins.
CHEST  , DOI: ( /chest )
Copyright © 1991 The American College of Chest Physicians Terms and Conditions